Skip to main content
. 2020 Apr 14;21(8):2715. doi: 10.3390/ijms21082715

Figure 3.

Figure 3

Percentage of cases detected by RAD51B XRCC3 gene panel in tumor tissue samples (Positive 92%, Negative 8%) and in gynecomastia tissue samples (Positive 89%, Negative 11%).